Abiraterone

Overview

Abiraterone blocks the synthesis of androgens by inhibiting CYP17A1. It is used to treat metastatic, castration-resistant prostate cancer.

Application

Products > Drug Discovery > Impurities > Anti-Neoplastic > Abiraterone Acetate and Impurities | Products > Drug Discovery > Inhibitor

Product Information

• Catalog No.: B0084-059670
• CAS No.: 154229-19-3
• Molecular Formula: C24H31NO
• Molecular Weight: 349.51
• Purity: >98%

Source

Original product source